Additionally, GEM is reported to suppress epidermal growth factor receptor (EGFR) by stimulating the expression of casitas B-lineage lymphoma (CBL) that promotes ubiquitination degradation of EGFR and inhibits tumor progression (Jang et al., 2020). Here, EGFR is linked to neoplasm.